Harprit Singh: India’s Silent Transfusion Gap – What Policymakers Need to Know in 2026
Harprit Singh, Associate Director at Transfusion Technologies, Therapies, Solutions and Consultant in Transfusion Medicine at Alchemist Hospital, shared a post on LinkedIn:
“India’s Silent Transfusion Gap: What Policymakers Need to Know in 2026
India has made substantial progress in blood collection and safety standards over the years. Yet, alongside these achievements, a quieter challenge continues to surface in clinical settings.
It faces a transfusion systems gap.
Every year, hospitals reporting adequate collections still miss timely transfusion, plasma exchange, or transplant readiness when it matters most.
This gap is not about donor numbers but how blood moves through the health system.
Across tertiary hospitals, I see the same pattern:
- Blood centres work hard
- Clinicians work harder
- Outcomes still vary widely
Why?
Because blood centres and transfusion medicine are used interchangeably — often treated as a logistics function, not a clinical and strategic one.
Where the opportunity for strengthening systems lies:
- Reactive blood demand forecasting
- Component availability is tracked, but not clinical readiness
- Apheresis capacity is not integrated into ICU, transplant, or similar service delivery decision-making
- Data flows upward for reporting, not sideways for action
These are system design opportunities
Global guidance from the World Health Organization and national frameworks under MoHFW India consistently emphasise haemovigilance, traceability, and integration.
Implementation progress varies understandably across regions, hospital types, and resource settings.
The next phase of reform is an enabling architecture
An architecture that facilitates coordination, visibility, and prompt decision-making throughout various care pathways is essential.
As 2026 approaches, policymakers and health system leaders may find value in asking new questions: ‘How reliably did transfusion services support critical care, transplants, and emergency response when needed?’
Hospitals that close this gap see quieter benefits:
- Fewer last-minute escalations
- Better transplant readiness
- Lower wastage
- Higher public trust
This is where clinical expertise, operational leadership, and policy design naturally converge toward the rational and equitable use of blood.
Leadership prompt:
If you are shaping policy, accreditation, or large hospital systems, I’m always open to exchanging perspectives on building transfusion intelligence at scale. Many of the most meaningful improvements I’ve seen began with a single strategic conversation.
- Which part of your transfusion pathway would fail first if demand surged tomorrow?
- How prepared is your organisation for the next inflection point?”
David McIntosh, Founder and Chair of United Plasma Action, shared this post on LinkedIn, adding:
“This post from a knowledgeable front-line practitioner in India is good relevant reading for folks in other countries too!! ”
Stay updated with Hemostasis Today.
-
May 23, 2026, 14:48Sam Zeraatain Nejad Davani: Off-Pump Surgery for COVID-19 Right Atrial Thrombosis
-
May 23, 2026, 14:42How Should Evidence Be Interpreted in Modern Hemophilia Care? – GARDEN
-
May 23, 2026, 12:52Fernanda Orsi: Honor to Be Speaking on ITP Diiferential Diagnosis at the 2026 Highlights of ASH
-
May 23, 2026, 12:46Jayagowri Karthikeyan: Grateful to Receive NBEMS President’s Gold Medal for Excellence In Immunohematology and Blood Transfusion
-
May 23, 2026, 12:40Aryabhatta Sadhu: Redefining Transfusion Medicine Across Obstetrics, Gynecology, and Fetal Medicine
-
May 23, 2026, 12:03Kiana Mohammadian: Do Anti-Inflammatory Cytokines Modulate Thrombosis?
-
May 23, 2026, 11:55Zikra Tazeen Mohammad Zakriya: Exploring the Link Between Vitamin D, Stroke, and Thrombosis
-
May 23, 2026, 11:33Alessandra Bosch: Swiss Delphi Consensus Study on Thrombophilia Testing Indications
-
May 23, 2026, 11:21Dip Ghosh: How CPDA-1 Keeps Transfusions Safe and Effective